dr. Chris Monten (MD,PhD)

CRIG member


Resident, department of radiation oncology, Ghent University Hospital
Postdoctoral researcher, Fac. of medicine and Health Sciences, department of Human Structure and Repair
Chairman of the Commission of Reimbursement for Implants and Invasive Medical Devices, NIHDI
Principal investigator: prof. Liv Veldeman (MD, PhD)

Resident, lymphedema clinic, Ghent University Hospital, Principal investigator

 

Research focus

  • Topic 1:  Adjuvant breast radiotherapy: toxicity as well as effectiveness of acceleration of radiotherapy to five fractions
  • Topic 2: Cost-effectiveness of different adjuvant breast radiotherapy schedules through time driven-activity based costing analysis (collaboration with Den Haag)
  • Topic 3: Treatment of lymphedema as treatment-related complication:
    - EFFORT-bcrl trial: effectiveness of manual lymph drainage for upper limb lymphedema after breast cancer
    - prospective cohort of patients undergoing gynaeco-oncologic treatment to detect prognostic factors, to develop a strategy for detection of early lymphedema and to evaluate the effect of compressive garment in early stage lymphedema
     

Key publications

  • “Adoption of single fraction radiotherapy for uncomplicated bonemetastases in a tertiary centre” 2021. ctRO
  • “5-year outcomes of a randomized trial comparing prone and supine whole breast irradiation in large breasted women” 2021. IJROBP
  • “Acute toxicity and health-related quality of life after accelerated whole breast irradiation in 5 fractions with simultaneous integrated boost” 2021, The Breast
  • “Crawl positioning improves set-up precision and patient comfort in prone whole breast irradiation” 2020. Scientific Reports
  • “Feasibility study on pre or postoperative accelerated radiotherapy (POP-ART) in breast cancer patients” 2020. Pilot and Feasiblity Studies
  • “Health-related quality of life after accelerated breast irradiation in five fractions: A comparison with fifteen fractions. 2020” Radiotherapy and Oncology
  • “Two-year toxicity of hypofractionated breast cancer radiotherapy in five fractions. 2020.” Acta Oncologica
  • “A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer. 2019.” Radiotherapy and Oncology
  • “Burn-out Bij Belgische Arts-specialisten in Opleiding: Exploratie Van Het Relatieve Belang Van Werkorganisatorische Risicofactoren.” 2019, Onco Hemato 12 (7): 8–12.
     

Contact & links

  • Lab address: Department of Radiation Oncology, Ghent University Hospital, Route 980, C. Heymanslaan 10, 9000 Ghent
  • Chris Monten is interested to receive invitations for presentations or talks